Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Top Cited Papers
Open Access
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 24 (2), 157-167
- https://doi.org/10.1038/modpathol.2010.200
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseBreast Cancer Research and Treatment, 2009
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast TumorsCancer Cell, 2007
- Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsBreast Cancer Research and Treatment, 2007
- Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysisBreast Cancer Research and Treatment, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markersBreast Cancer Research and Treatment, 2005
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004